The FTSE 100 Index fell 33.70 points, or 0.54%, to 6,180 points today after a gloomy performance from drug companies.
AstraZeneca tumbled 8.16% to £28.80 on news it has stopped the development of its experimental stroke drug NXY-059, as it failed to reduce significant disability in patients. GlaxoSmithKline slipped 3.97% to £14.51 despite raising earnings guidance for the year to mid-teens EPS growth from 12% previously, hiking its dividend and increasing its share buyback programme. British American Tobacco also fell 1.55% to £14.59, despite lifting nine month earnings by 13% to 75p, adding it is on track for a good year. Life insurer Aviva dropped 1.89% to £7.77 after it reported it had boosted nin...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes